These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors. Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980 [TBL] [Abstract][Full Text] [Related]
4. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor. Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824 [TBL] [Abstract][Full Text] [Related]
5. Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides. Schiller PW; Nguyen TM; DiMaio J; Lemieux C Life Sci; 1983; 33 Suppl 1():319-22. PubMed ID: 6319885 [TBL] [Abstract][Full Text] [Related]
7. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands. Pfeiffer A; Herz A Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680 [TBL] [Abstract][Full Text] [Related]
9. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery. Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F Peptides; 1982; 3(5):793-7. PubMed ID: 6294635 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors. Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735 [TBL] [Abstract][Full Text] [Related]
12. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs. Zadina JE; Kastin AJ; Ge LJ; Hackler L Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646 [TBL] [Abstract][Full Text] [Related]
13. In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists. Martín MI; Alfaro MJ; Goicoechea C; Colado MI Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):324-8. PubMed ID: 8386807 [TBL] [Abstract][Full Text] [Related]
14. Receptors for opioid peptides in the guinea-pig ileum. Takemori AE; Portoghese PS J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432 [TBL] [Abstract][Full Text] [Related]
15. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency. Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442 [TBL] [Abstract][Full Text] [Related]
16. Opioid activity of enkephalin analogues containing the kyotorphin-related structure in the N-terminus. Amano H; Morimoto Y; Kaneko S; Takagi H Neuropharmacology; 1984 Apr; 23(4):395-400. PubMed ID: 6328351 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286 [TBL] [Abstract][Full Text] [Related]